Key Insights

Highlights

Success Rate

91% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.3%

3 terminated out of 69 trials

Success Rate

91.2%

+4.7% vs benchmark

Late-Stage Pipeline

6%

4 trials in Phase 3/4

Results Transparency

6%

2 of 31 completed with results

Key Signals

2 with results91% success

Data Visualizations

Phase Distribution

53Total
Not Applicable (37)
P 1 (5)
P 2 (7)
P 3 (2)
P 4 (2)

Trial Status

Completed31
Recruiting14
Not Yet Recruiting11
Enrolling By Invitation3
Withdrawn3
Terminated3

Trial Success Rate

91.2%

Benchmark: 86.5%

Based on 31 completed trials

Clinical Trials (69)

Showing 20 of 20 trials
NCT06940596Not ApplicableRecruitingPrimary

Exclude or Expose in Irritable Bowel Syndrome: What Works for Whom and How?

NCT05630703Not ApplicableWithdrawnPrimary

Mindfulness Training Versus Low (FODMAP) Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols Diet

NCT07176078Not ApplicableRecruitingPrimary

Evaluating the Added Benefit of Osteopathic Care to a Flexi-FODMAP Diet in Fibromyalgia Patients With Irritable Bowel Syndrome

NCT07481422Phase 1RecruitingPrimary

Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndrome

NCT07475299Not ApplicableNot Yet RecruitingPrimary

Synbiotic Supplement With Botanical Extracts for Gut Microbiota Balance in Irritable Bowel Syndrome

NCT07052890Not ApplicableCompletedPrimary

Curcumin, Vitamin D and Green Tea in IBS-D

NCT07345377Not ApplicableEnrolling By InvitationPrimary

Study on Treatment Mechanisms and Efficacy Prediction of Individualized Transcranial Magnetic Stimulation in Adults With Irritable Bowel Syndrome Using Multimodal MRI and High-Throughput Sequencing

NCT07337707Not ApplicableNot Yet RecruitingPrimary

New Microbiota-endocrine Axis in Fructose Malabsorption-caused Visceral Hypersensitivity in Irritable Bowel Syndrome.

NCT05795049Active Not RecruitingPrimary

Genetic Carbohydrate Maldigestion as a Model to Study Food Hypersensitivity

NCT07283341RecruitingPrimary

Diet and Motility in IBS

NCT06653647Not ApplicableCompleted

Efficacy of Guided Imagery Therapy Mobile Application for Functional Abdominal Pain

NCT06668922Not ApplicableRecruitingPrimary

Irritable Bowel Syndrome and Control Volunteers: Diet Challenge

NCT07261826Recruiting

Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics

NCT07222943Not ApplicableNot Yet Recruiting

Feasibility Study of a Guided Imagery Therapy Mobile Application for Functional Abdominal Pain Disorders in Children

NCT06676488Not ApplicableRecruitingPrimary

A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome

NCT07125625Not ApplicableNot Yet RecruitingPrimary

Probiotic Mixture (L. Rhamnosus GG and L. Plantarum 299V) In Pediatric Irritable Bowel Syndrome

NCT07000227Not ApplicableRecruiting

Mechanism of FODMAP Restriction on FGID Patients

NCT04031469Suspended

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

NCT07051226Not Yet RecruitingPrimary

Deep Learning-Based Confocal Laser Microendoscopy Feature Atlas Construction and Its Application in Intelligent Diagnosis of Irritable Bowel Syndrome

NCT06657001Enrolling By Invitation

Enabling Microbiomics- Driven Personalized Nutrition

Scroll to load more

Research Network

Activity Timeline